Skip to main content
Nxera Pharma Co., Ltd. logo

Nxera Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4565 ISIN · JP3431300007 LEI · 2138004M62BFNJMR2Z82 T Manufacturing
Filings indexed 107 across all filing types
Latest filing 2026-04-15 Share Issue/Capital Cha…
Country JP Japan
Listing T 4565

About Nxera Pharma Co., Ltd.

https://www.nxera.life/

Nxera Pharma Co., Ltd. (formerly Sosei Group Corp.) is a technology-driven biopharmaceutical company focused on the discovery and early development of novel medicines. The company utilizes its proprietary StaR® technology and world-leading expertise in G protein-coupled receptor (GPCR) structure-based drug design (SBDD) to create therapeutics for diseases with high unmet medical needs. By integrating advanced science and technology, Nxera Pharma develops its internal pipeline and collaborates with partners to accelerate the creation of life-changing treatments for patients worldwide. Its mission is to invest in science and technology to accelerate the development of these medicines.

Recent filings

Filing Released Lang Actions
訂正有価証券届出書(参照方式)
Share Issue/Capital Change Classification · 1% confidence The document is a full securities registration statement (有価証券届出書) detailing a new share issuance under an RSU plan—covering issue size, conditions, pricing, and legal disclosures. It is not an annual report, earnings release, or management discussion, but a prospectus for capital increase via share issuance. This fits the “Share Issue/Capital Change” category (SHA).
2026-04-15 Japanese
訂正有価証券届出書(参照方式)
Share Issue/Capital Change Classification · 1% confidence The document is a full securities registration statement (有価証券届出書) detailing the issuance and allotment of new shares (RSUs), including the number of shares, conditions of issuance, use of proceeds, and related procedures. This corresponds to an announcement and documentation of a new share issue / capital change. Therefore it best fits the “Share Issue/Capital Change” category (SHA).
2026-04-15 Japanese
臨時報告書
Share Issue/Capital Change Classification · 1% confidence The document is a Japanese “臨時報告書” (extraordinary report) filed under the Financial Instruments and Exchange Act, detailing the issuance of restricted stock units (RSUs) to officers and employees, including the number of shares, issue price, capital increase amounts, and shareholder allocation. This is a capital change / share issuance announcement, matching our “Share Issue/Capital Change” category. It is not an earnings release, management change, proxy statement, or dividend notice. Therefore it should be classified as SHA.
2026-04-15 Japanese
臨時報告書
Share Issue/Capital Change Classification · 1% confidence The document is a Japanese “臨時報告書” (“Timely Disclosure” under the Financial Instruments and Exchange Act) dated April 15, 2026. Section 2 details the planned issuance of 1,236,400 new common shares at ¥1,011 each to fund a retirement‐type stock benefit trust (J-ESOP), including issuance price, capital increase amounts, and related trust mechanics. This is clearly an announcement of a new share issue/capital change rather than a full annual or interim report or other category. Therefore, it fits the “Share Issue/Capital Change” category (SHA).
2026-04-15 Japanese
訂正有価証券届出書(参照方式)
Share Issue/Capital Change Classification · 1% confidence The document is a formal Japanese Securities Registration Statement (有価証券届出書) filed with the Kanto Finance Bureau detailing the terms and conditions of a new share issuance under an RSU plan, including number of shares, issue price, allocation method, and related corporate actions. It is clearly an announcement and registration of a new share issuance (capital change) rather than an annual report or other regulatory filing. This aligns with the “Share Issue/Capital Change” category.
2026-03-25 Japanese
訂正有価証券届出書(参照方式)
Share Issue/Capital Change Classification · 1% confidence The document is a Japanese 有価証券届出書 (securities registration statement) filed with the Kanto Finance Bureau detailing the terms, number of shares, allotment conditions and procedures for a new share issuance under the company’s RSU plan. It is not an annual/quarterly report or mere publication notice, but a full prospectus‐style registration related to share issuance / capital change. Therefore, it should be classified under Share Issue/Capital Change (SHA).
2026-03-25 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.